Glucagon-like peptide-1 receptor agonists, compositions thereof, and uses thereof
TW202641821APending Publication Date: 2026-10-16METSERA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115100578
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-07
- Filing Date
- 2026-01-07
- Publication Date
- 2026-10-16
Smart Images
Figure TWG2TA001080884_001 
Figure TWG2TA001080884_002 
Figure TWG2TA001080884_003
Abstract
The present disclosure provides peptides useful for weight loss, weight maintenance, and the treatment of metabolic disorders. In some embodiments, peptides described herein are prodrugs of active GLP-1 agonist peptides, and therefore may exhibit extended half-life and / or improved therapeutic index compared to existing GLP-1 agonist peptides. Use of the peptides described herein can reduce the risk of side effects and improve individual (e.g., patient, subject, etc.) compliance when compared with current standards.
Need to check novelty before this filing date? Find Prior Art